Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study
Research output: Contribution to journal › Journal article › Research › peer-review
The benefit of extending clopidogrel treatment beyond the 12-month period recommended in current guidelines after myocardial infarction (MI) is debated. We analysed the risk of adverse cardiovascular outcomes after discontinuation of 12 months of clopidogrel treatment.
| Original language | English |
|---|---|
| Journal | European Heart Journal |
| Volume | 33 |
| Issue number | 20 |
| Pages (from-to) | 2527-34 |
| Number of pages | 8 |
| ISSN | 0195-668X |
| DOIs | |
| Publication status | Published - 2012 |
ID: 48453033